CN107050438A - Beautiful-skin-promoagent agent and use thereof - Google Patents
Beautiful-skin-promoagent agent and use thereof Download PDFInfo
- Publication number
- CN107050438A CN107050438A CN201611137754.7A CN201611137754A CN107050438A CN 107050438 A CN107050438 A CN 107050438A CN 201611137754 A CN201611137754 A CN 201611137754A CN 107050438 A CN107050438 A CN 107050438A
- Authority
- CN
- China
- Prior art keywords
- flesh
- lipoic acid
- sample
- accelerator
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 claims abstract description 67
- 239000000203 mixture Substances 0.000 claims abstract description 53
- 102000008186 Collagen Human genes 0.000 claims abstract description 46
- 108010035532 Collagen Proteins 0.000 claims abstract description 46
- 229920001436 collagen Polymers 0.000 claims abstract description 46
- 235000018597 common camellia Nutrition 0.000 claims abstract description 45
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 35
- 230000017531 blood circulation Effects 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 31
- 230000001976 improved effect Effects 0.000 claims abstract description 13
- 230000009467 reduction Effects 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 8
- 230000003796 beauty Effects 0.000 claims abstract description 6
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical class [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims abstract 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 235000019136 lipoic acid Nutrition 0.000 claims description 53
- 229960002663 thioctic acid Drugs 0.000 claims description 42
- 150000002632 lipids Chemical class 0.000 claims description 41
- 239000000463 material Substances 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 21
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 21
- 108010010803 Gelatin Proteins 0.000 claims description 17
- 239000008273 gelatin Substances 0.000 claims description 17
- 229920000159 gelatin Polymers 0.000 claims description 17
- 235000019322 gelatine Nutrition 0.000 claims description 17
- 235000011852 gelatine desserts Nutrition 0.000 claims description 17
- 238000002425 crystallisation Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 240000007594 Oryza sativa Species 0.000 claims description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 235000005911 diet Nutrition 0.000 claims description 13
- 230000037213 diet Effects 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 238000005238 degreasing Methods 0.000 claims description 12
- 229920000858 Cyclodextrin Polymers 0.000 claims description 10
- 238000005253 cladding Methods 0.000 claims description 10
- 235000017709 saponins Nutrition 0.000 claims description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 9
- 230000004048 modification Effects 0.000 claims description 8
- 238000012986 modification Methods 0.000 claims description 8
- 229930182490 saponin Natural products 0.000 claims description 7
- 150000007949 saponins Chemical class 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- YDGQDJXYFVWQDO-UHFFFAOYSA-N camelliasaponin B1 Natural products CC=C(/C)C(=O)OC1CC(C)(C)CC2C3=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OCC(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C6OC9OC(CO)C(O)C(O)C9O)C(C)(C=O)C5CCC4(C)C3(C)CC(O)C12CO YDGQDJXYFVWQDO-UHFFFAOYSA-N 0.000 claims description 2
- MGTOPLIWMNGFCQ-UHFFFAOYSA-N camelliasaponin B2 Natural products O=CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(C)=CC)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C(O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O MGTOPLIWMNGFCQ-UHFFFAOYSA-N 0.000 claims description 2
- MGTOPLIWMNGFCQ-PGGKNCGUSA-N camelliasaponin b2 Chemical compound O=CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(/C)=C/C)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C(O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O MGTOPLIWMNGFCQ-PGGKNCGUSA-N 0.000 claims description 2
- 241000209507 Camellia Species 0.000 claims 5
- 240000001548 Camellia japonica Species 0.000 abstract description 42
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical class C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 abstract description 37
- 239000000419 plant extract Substances 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 6
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical class OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 74
- 210000003491 skin Anatomy 0.000 description 47
- 235000019441 ethanol Nutrition 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 31
- 230000000694 effects Effects 0.000 description 30
- -1 moisture Substances 0.000 description 27
- 239000000047 product Substances 0.000 description 27
- 239000011248 coating agent Substances 0.000 description 25
- 238000000576 coating method Methods 0.000 description 25
- 238000004519 manufacturing process Methods 0.000 description 24
- 239000002253 acid Substances 0.000 description 21
- 239000000126 substance Substances 0.000 description 19
- 239000000835 fiber Substances 0.000 description 18
- 239000002994 raw material Substances 0.000 description 18
- 238000002156 mixing Methods 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 239000001993 wax Chemical class 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 12
- 239000000306 component Substances 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 description 10
- 244000194101 Ginkgo biloba Species 0.000 description 10
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 10
- 239000002775 capsule Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000021283 resveratrol Nutrition 0.000 description 10
- 229940016667 resveratrol Drugs 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241000219095 Vitis Species 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 235000009754 Vitis X bourquina Nutrition 0.000 description 8
- 235000012333 Vitis X labruscana Nutrition 0.000 description 8
- 235000014787 Vitis vinifera Nutrition 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000825 pharmaceutical preparation Substances 0.000 description 8
- 229940127557 pharmaceutical product Drugs 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 240000004371 Panax ginseng Species 0.000 description 6
- 235000002789 Panax ginseng Nutrition 0.000 description 6
- 241000425037 Toona sinensis Species 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 239000004519 grease Substances 0.000 description 6
- 239000007887 hard shell capsule Substances 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 239000005864 Sulphur Substances 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- RJWUMFHQJJBBOD-UHFFFAOYSA-N 2-methylheptadecane Chemical compound CCCCCCCCCCCCCCCC(C)C RJWUMFHQJJBBOD-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 240000006846 Camellia reticulata Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229920001800 Shellac Polymers 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229960004203 carnitine Drugs 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 150000002118 epoxides Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 229940116257 pepper extract Drugs 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 3
- 239000004208 shellac Substances 0.000 description 3
- 229940113147 shellac Drugs 0.000 description 3
- 235000013874 shellac Nutrition 0.000 description 3
- 230000005808 skin problem Effects 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 2
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241001328788 Camellia nitidissima Species 0.000 description 2
- 235000000658 Camellia reticulata Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 2
- 240000001238 Gaultheria procumbens Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 240000002836 Ipomoea tricolor Species 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 235000005087 Malus prunifolia Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 241000276701 Oreochromis mossambicus Species 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000010394 Solidago odora Nutrition 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 235000009932 Zanthoxylum simulans Nutrition 0.000 description 2
- 244000089698 Zanthoxylum simulans Species 0.000 description 2
- 229920002494 Zein Polymers 0.000 description 2
- 108010055615 Zein Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940092738 beeswax Drugs 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 241001233037 catfish Species 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 244000192963 common camellia Species 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 229940043348 myristyl alcohol Drugs 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 229940119485 safflower extract Drugs 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 235000018991 trans-resveratrol Nutrition 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 239000005019 zein Substances 0.000 description 2
- 229940093612 zein Drugs 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- FROLUYNBHPUZQU-IIZJPUEISA-N (2R,3R,4S,5R)-2-(hydroxymethyl)-6-[3-[3-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropoxy]propoxy]oxane-3,4,5-triol Chemical compound OC[C@H]1OC(OCCCOCCCOC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O FROLUYNBHPUZQU-IIZJPUEISA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- ZAUYNCUCMJDAHW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;hydrogen peroxide;molecular iodine Chemical compound OO.II.C=CN1CCCC1=O ZAUYNCUCMJDAHW-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical class CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- RZYKUPXRYIOEME-UHFFFAOYSA-N CCCCCCCCCCCC[S] Chemical compound CCCCCCCCCCCC[S] RZYKUPXRYIOEME-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 244000192967 Camellia japonica var. rusticana Species 0.000 description 1
- 241000772894 Camellia pitardii var. pitardii Species 0.000 description 1
- 241001552456 Camellia salicifolia Species 0.000 description 1
- 241001343471 Camellia saluenensis Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000006122 Chenopodium album Species 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- SDTOABMYDICPQU-UHFFFAOYSA-N Genkwanin Natural products C=1C(C)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 SDTOABMYDICPQU-UHFFFAOYSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- DZUKXCCSULKRJA-UHFFFAOYSA-N Isopratol Natural products C=1C(OC)=CC=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 DZUKXCCSULKRJA-UHFFFAOYSA-N 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001147156 Lates niloticus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- QUZHZFAQJATMCA-UHFFFAOYSA-N Monogalactosyldiglyceride Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCC=CCC)COC1OC(CO)C(O)C(O)C1O QUZHZFAQJATMCA-UHFFFAOYSA-N 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000266501 Ormosia ormondii Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001529596 Pontinus kuhlii Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001061106 Sargocentron rubrum Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001062811 Stewartia malacodendron Species 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 241000489523 Veratrum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- IZFHEQBZOYJLPK-UHFFFAOYSA-N dihydrolipoic acid Chemical class OC(=O)CCCCC(S)CCS IZFHEQBZOYJLPK-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229920001968 ellagitannin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- JPMYFOBNRRGFNO-UHFFFAOYSA-N genkwanin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 JPMYFOBNRRGFNO-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000003077 lignite Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Chemical compound CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- LUPNKHXLFSSUGS-UHFFFAOYSA-M sodium;2,2-dichloroacetate Chemical compound [Na+].[O-]C(=O)C(Cl)Cl LUPNKHXLFSSUGS-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The problem of the present invention is that providing a kind of skin condition to the drying, elastic reduction, pachylosis of skin etc. is improved and/or promoted the U.S. flesh accelerator of U.S. flesh, coordinates the U.S. flesh accelerator and formed and the beauty method for promoting the composition for oral administration of U.S. flesh and for improving skin condition and/or promoting U.S. flesh.There is provided as active ingredient containing collagen peptide and improving blood flow agent and U.S. flesh accelerator with thing, the method for coordinating composition for oral administration, the above-mentioned U.S. flesh accelerator of orally ingestible or above-mentioned composition formed by above-mentioned U.S. flesh accelerator, improving blood flow agent is particularly the one or more selected from the group being made up of camellia seed extract, lipoic acid class, resveratrol class and plant extracts containing resveratrol class.
Description
Present patent application is that (international application no is PCT/JP2012/ to Application No. 201280020408.4
061191), the applying date is on April 26th, 2012, the application for a patent for invention of entitled " Beautiful-skin-promoagent agent and use thereof "
Divisional application.
Technical field
The present invention relates to a kind of U.S. flesh accelerator, coordinate composition for oral administration and its utilization formed by the U.S. flesh accelerator
Method.Wherein, U.S. flesh accelerator is characterised by that contain collagen peptide and improving blood flow agent forms as active ingredient, uses
Improved and/or for forming more beautiful skin in the wrinkle of skin, the skin problem for moistening, compacting, relaxing etc..
Background technology
Skin is made up of epidermis, corium, hypodermis.Epidermis is made up of cuticula, stratum granulosum, spinous layer and basalis, greatly
The cell containing keratinocyte, melanocyte etc. is measured, playing prevents from extraneous harmful substance or pathogen invasion or press down
The effect of moisture evaporation processed.Different from epidermis in the dermis, cell is few, the collagen or bullet produced by fiber sprout cell
Property albumen etc. the extracellular components such as the mucopolysaccharide of protein, hyaluronic acid or chondroitin sulfate etc. occupied by, form matrix
Structure and realize following effect:Support cell and skin histology, the moisture kept in space between cells, the lubricity for keeping skin and
Flexibility, from from ultraviolet, dry environment, mechanical irritation or damage, microorganism infection etc. external factor protect skin
Organize (non-patent literature 1).
But, increase or daily ultraviolet of the above-mentioned extracellular matrix components by the age are influenceed and are denatured, decomposed, and
And decaying according to fiber sprout cell, its synthetic quantity also reduces.It is well known that the decomposition of above-mentioned extracellular matrix and synthetic quantity drop
It is low, dry skin, pachylosis, elasticity or flexibility reduction can be caused, compact sense or gloss reduce, it is increase wrinkle, relaxation, dark
The various skin problems of light grade.Therefore, skin is beautified in order to improve skin state and/or maintain to promote, it is desirable to make skin cell
Activation, supplement further enhance it because of the composition of age increase or ultraviolet reduction.Particularly, collagen accounts for skin
About the 70% of the dry weight of skin tissue, the viscoplasticity with skin is closely related.Also, hyaluronic acid is the guarantor to skin histology
The wet material for having a significant impact, thus maintain, the collagen in enhancing skin histology and hyaluronic acid are vital.
In order to strengthen using collagen or hyaluronic acid as the composition in the skin histology of representative, or suppression skin is old
Change, various composition is have studied so far, analyte (patent document 1), the N- acetyl Portugal of gelatin and/or collagen is currently suggested
Osamine (patent document 2), sphingomyelin (patent document 3), Genkwanin (patent document 4), raspberry (patent document 5) etc..
But, physiological action that above material has to be presented in vivo, it is necessary to absorb in large quantities, even and if
It is also and indefinite according to personal effect by taken long-term, and the situation of desired effects also can not be obtained, the energy from practicality
The situation that validity is enough presented is less.Accordingly, it would be desirable to which developing a kind of can effectively facilitate the material or composition of above-mentioned U.S. flesh.
Here, improving blood flow agent refers to the improvement improved to the function that blood is transported in each tissue of organism
Agent.Blood is carried out to distal tissues supply oxygen, nutritional ingredient, moisture, hormone etc., is carried immunocyte, discharge metabolin, is adjusted
Body temperature etc. is saved, very important role is assume responsibility in the function of bio-tissue is maintained.It is well known that by improving blood flow,
Artery sclerosis symptom, hypertension symptom, immunity degradation, alopecia symptom, fatigue, edema, shoulder acid, chilly, trick can be relaxed
The symptom of numb, livid ring around eye or skin dimness etc..
As the material of blood flow is improved, proposition has such as ginkgo biloba p.e, safflower extract, intacellin, capsicum
Extract, capsaicine, panax ginseng extractum, Japanese Herba Swertiae bimaculatae extract, pheophytin, vitamin e and its derivative (vitamin E acetate
Deng), pantothenic acid and its salt (calcium salt, sodium salt etc.), glycyrrhizic acid or enoxolone and their salt (sodium salt, sylvite etc.), variegated leaf campanilla
Extract, arginine and its derivative (arginine glutamic acid etc.), nicotinic acid and its derivative (methyl esters etc.), rosemary is set to extract
Thing, Ginger P.E, salad oil, gingerol, zingerone, isoflavones, vitamin B3, Turmeric P.E, the seed of grape, leaf, stem
Deng extract, Extraction of rutin thing, fermentation rice germ extract, angelica extract, garlic extract, Chinese pepper extract etc..
But, research is not found suppresses the combination of composition to skin histology on these improving blood flow materials and above-mentioned skin ageing
Or the report of influence caused by skin state.
Prior art literature
Patent document
Patent document 1:Japanese Unexamined Patent Publication 2004-123637 publications
Patent document 2:Japanese Unexamined Patent Publication 2001-48789 publications
Patent document 3:Japanese Unexamined Patent Publication 2005-281257 publications
Patent document 4:Japanese Unexamined Patent Publication 2004-137217 publications
Patent document 5:Japanese Unexamined Patent Publication 2003-137801 publications
Non-patent literature
Non-patent literature 1:Fu Bu roads are wide,《The science of skin nursing》, page 6~page 14, (strain) skirt China room, 1997
Issue within 25 days 2 months
The content of the invention
Technical problem
In view of related present situation, the present inventors are using the description below as problem, i.e. the U.S. flesh accelerator of exploitation to scaly dry skin,
The skin state of elastic reduction, pachylosis etc. is improved and/or promoted U.S. flesh to be formed there is provided the U.S. flesh accelerator is coordinated
The composition for oral administration for being used to promote U.S. flesh and for improving skin state and/or promoting the method for U.S. flesh.
Technical scheme
In order to solve above-mentioned problem, the present inventors are carried out repeatedly with keen determination to the relevance of various materials and U.S. flesh
The result of discussion finds that the combination of collagen peptide and the material acted on improving blood flow unexpectedly produces remarkable result, especially
It from camellia seed extract, lipoic acid class, resveratrol class and contains white black false hellebore in the material acted on improving blood flow
At least one selected in the plant extracts of alcohols is used together especially effective with collagen peptide.Also, it is also found that it was possible to
In the Orally administered composition that it is effectively used in diet product, feed, pharmaceuticals, non-pharmaceutical products etc., so as to complete the present invention.
That is, it is a feature of the present invention that containing improving blood flow agent and collagen peptide as active ingredient and forming U.S. flesh
Accelerator.In the U.S. flesh accelerator, collagen peptide is preferably adding water by collagen, gelatin and collagen and gelatin
The one or more selected in the group of analyte composition, above-mentioned hydrolyzable thing is preferably its molecular weight (mean molecule
Amount, same as below) it is about 200~about 10000.Also, improving blood flow agent is particularly preferably from camellia seed extract, lipoic acid
Selected in the group of class, resveratrol class and plant extracts composition containing resveratrol class it is at least one or two with
On.
Above-mentioned camellia seed extract is containing the degreasing dregs of rice progress extraction process institute for passing through water and/or lower alcohol to camellia seed
The extract of obtained water composition, is preferably the extract containing saponins, the saponins is especially preferably from Tsubaki-saponin
(Camelliasaponin) A1, Tsubaki-saponin A2, Tsubaki-saponin B1, Camelliasaponin B2, Tsubaki-saponin C1 and Tsubaki-saponin
The one or more selected in C2.
Also, lipoic acid class is preferably by lipoic acid (including racemic modification), its reduced form, their salt, their ester
The one kind or two selected in the group of compound, their acid amides and their cyclodextrin inclusion compound or lipid coating composition
Plant the compound of the above.
Further, resveratrol class be preferably from the polymer of the monomer by resveratrol or ε-grape element etc. and it
Isomers and/or glucoside composition group in the one or more selected, its more preferred form is Vitaceae
The extract of plant, polygonaceae plant or legume.
Other of the present invention are characterised by that the material preferably as the above-mentioned U.S. flesh accelerator of orally ingestible or administration is oral
With composition, and the composition for oral administration is diet product.Other are further characterized in that, orally ingestible collagen peptide and improving blood flow
Agent and improved and/or promoted the side of U.S. flesh for the skin state to the drying of skin, elastic reduction, pachylosis etc.
Method, especially beauty method.
Beneficial effect
The U.S. flesh accelerator of the present invention is contained collagen peptide and improving blood flow agent and formed, and the stability of quality etc. is excellent
It is different, act on Skin Cell to significantly improve its propagation, promote the generation of the skin components of collagen hyaluronic acid etc., it is extensive
Composition in multiple, maintenance, enhancing skin histology.By by improving blood flow agent especially from camellia seed extract, lipoic acid class, white lamb's-quarters
Select at least one to be used together with collagen peptide in reed alcohols, make its effect enhancing.Thus, following effect is produced, i.e. right
The drying of skin, coarse, elastic or flexibility reduction, the reduction of gloss, the increasing of wrinkle, the increasing of relaxation, dim increasing
Plus the skin problem waited is prevented and/or improved, and further promote U.S. flesh.Promoted by the above-mentioned U.S. flesh of orally ingestible or administration
Enter agent and significantly find related effect.Therefore, above-mentioned U.S. flesh accelerator is particularly in diet product, feed, pharmaceuticals, non-medicine
In the field of articles for use etc., directly it can be carried out with the form of above-mentioned preparation or with the form for being combined into conventional various products effectively
Utilize.Also, the present invention provides a kind of orally ingestible collagen peptide and improving blood flow agent and for the drying to skin, bullet
The skin state of property reduction, pachylosis etc. is improved and/or promoted the beauty method of U.S. flesh.
Embodiment
The present invention is described in detail below.First, U.S. flesh accelerator of the invention is characterized in that containing collagen egg
White peptide and improving blood flow agent are formed as active ingredient.
The collagen peptide used in the U.S. flesh accelerator of the present invention is, by the domestic animals of ox, pig, chicken, turkey, ostrich etc.
Skin, bone, cartilage or tendon etc. and red coat, salmon, shark, cod, Tilapia mossambica, Nile perch, carp, flat Rockfish fishes, tuna,
Skin, bone, cartilage or squama of the fish of catfish, eel etc. etc. are as raw material, glue obtained to being handled by common method
The gelatin that former albumen or make is obtained after the collagen thermal denaturation, the peptide of hydrolyzable and gained is carried out by acid, alkali or enzyme.
This, described collagen peptide includes collagen peptide and the extract containing collagen peptide in the present invention, and can be any
Use above-mentioned substance.It is relatively simple using commercially available product to collagen peptide.
In the present invention, it is preferred to carry out the collagen peptide after hydrolyzable, its molecule using to collagen or gelatin
Amount is about 200~about 10000, more preferably about 200~about 5000, more preferably about 200~about 1000.
Also, according to the improving blood flow agent of the U.S. flesh accelerator of the present invention, extract, the lipoic acid of camellia seed can be used
Class, resveratrol class, the plant extracts containing resveratrol class, ginkgo biloba p.e, safflower extract, intacellin,
Pepper extract, capsaicine, panax ginseng extractum, Japanese Herba Swertiae bimaculatae extract, pheophytin, vitamin e and its derivative (acetic vitamin
E etc.), pantothenic acid and its salt (calcium salt, sodium salt etc.), glycyrrhizic acid or enoxolone and their salt (sodium salt, sylvite etc.), variegated leaf campanilla
Extract, arginine and its derivative (arginine glutamic acid etc.), nicotinic acid and its derivative (methyl esters etc.), rosemary is set to extract
Thing, Ginger P.E, salad oil, gingerol, zingerone, isoflavones, vitamin B3, Turmeric P.E, the seed of grape, leaf, stem
Deng extract, Extraction of rutin thing, fermentation rice germ extract, angelica extract, garlic extract, Chinese pepper extract etc.,
And above-mentioned example is not limited to, one or more kinds of materials acted on improving blood flow can be used.
In connection with this, the inventors of the present invention with collagen peptide and use to by that can play more potent
Result that the improving blood flow agent of U.S. flesh facilitation effect is further studied in detail finds, the extract of camellia seed, lipoic acid class,
And resveratrol class or plant extracts containing resveratrol class it is extremely effective.That is, currently preferred U.S. flesh accelerator
The characteristics of be, collagen peptide is contained as active ingredient and from by camellia seed extract, lipoic acid class, resveratrol class
And containing resveratrol class plant extracts composition group in select one or more and formed.
The camellia seed extract for being related to the present invention is carried out described in detail below.Camellia, which refers to, belongs to Theaceae (Theaceae)
The camellia (camellia japonica) of the camellia system of Camellia (Camellia), can enumerate as example:Shallow lake overgrown with wild plants Chinese toon
(C.japonica var.japonica), snow mountain tea (C.japonica subsp.rusticana), Chinese pear-leaved crabapple Chinese toon
(C.japonica var.macrocarpa), phoenix camellia (C.japonica subsp.hozanensis), Hong Kong camellia
(C.hongkongenesis), Camellia reticulata (C.reticulata), Nujiang camellia (C.saluenensis), southwestern camellia class
(C.pitardii var.pitardii) and Camellia reticulata class (C.pitardii var.yunnanica), Camellia nitidissima
(C.nitidissima), wild camellia (of the same race with shallow lake overgrown with wild plants Chinese toon), camellia (of the same race with shallow lake overgrown with wild plants Chinese toon), the long island mountain tea in room are (same with Chinese pear-leaved crabapple Chinese toon
Kind) etc..These camellias suitably using Japanese Science Society, the Korea peninsula, Shandong Province of China peninsula etc. place naturally growth or cultivation and
Into camellia.
In order to manufacture the camellia seed extract according to the present invention, it is preferable that by the fruit of above-mentioned camellia and/or seed supply
The liquefaction of the hydrophobic organic solvent or liquefied carbon dioxide of hexane or heptane etc., liquefied propane etc. is handled and used to squeezing
In supercritical extract processing of gas etc., then the degreasing thing as residue that oil content is separated will be extracted by common method
(the hereinafter referred to as degreasing dregs of rice) are used as raw material.Here, during the fruit and/or seed of camellia can be precocious fruit and ripening fruits
Any one, can also use their seed, but if using ripening fruits or its seed, then degreasing thing or/and effectively
The amount to obtain of composition can become many, therefore preferably this scheme.More preferably use seed.It is preferred that, using to from into
The material that the seed obtained in ripe fruit is dried at 1~2 week or so, by sunshine etc..
It is preferably water composition according to the active component of the camellia seed extract of the present invention.The water composition can be with above-mentioned
The degreasing dregs of rice are manufactured as raw material by any means, it is preferred that to carry out extraction process using water and/or lower alcohol.Such as
The carbon number of fruit lower alcohol becomes big, then causes the tendency that the oily matter in the degreasing dregs of rice is extracted to increase, therefore lower alcohol
Preferably carbon number most 5 or so, can enumerate methanol, ethanol, normal propyl alcohol, isopropanol, n-butanol, isobutanol etc..Make
In the case of with the big lower alcohol of carbon number, in order to suppress to extract the oil components in the degreasing dregs of rice, moisture content can be improved.Example
Such as, make moisture content be about 20~about 50 mass % for propyl alcohol, make moisture content be about 40~about 70 mass % for butanol.It is preferred that
Extraction solvent be water, methanol and ethanol and its aqueous alcohol, more preferably water or moisture content containing for more than 50 mass %
Water methanol or hydrous ethanol, more preferably water.
When extracting the degreasing dregs of rice, the said extracted solvent of about 1~about 30 times of quality is added for the degreasing dregs of rice of 1 mass parts,
At ambient pressure or under the pressurization of about 1~about 5 atmospheric pressure, at a temperature of normal temperature~about 120 DEG C, about 10 minutes~about 3 hours,
As needed stirring and after being mixed, cooled and filtered under normal temperature, by being dried under reduced pressure, being spray-dried, freeze-dried etc.
Appropriate method is concentrated and dried to filtrate.Appropriate pulverization process can also be carried out to the dried object.It can so obtain
The faint yellow solid to crocus of the water soluble ingredient contained in camellia seeds as the present invention.Said extracted method passes through
Extraction residue after extraction process is repeated identical extraction process, or in the pressurization of about 1~about 3 atmospheric pressure
Under, and extraction process is carried out at about 100~about 130 DEG C, the amount to obtain of the water soluble ingredient of the present invention can be increased, also,
Said extracted thing is further carried out solvent point carry, the absorption by being filled with ion exchange resin, silica gel, activated alumina etc.
The classification of the tubing string of agent, concentration essence can be carried out to active component by the well-known means that liquid chromatography is separated etc.
System.The water soluble ingredient contains saponin(e, tannic acid etc..
As the saponin(e contained in above-mentioned water soluble ingredient, can enumerate as:As 3 β-[2-O- β-D- galactopyranosyls glycosyl-
3-O- (2-O- β-D- glucopyranosyl-α-L- arabopyranoses base)-beta d glucopyranosiduronic acid epoxide] olive-
12- alkene -16 α, 22 α, 28- triols 22- [(Z) -2- methyl-2-butenes acid esters] (3 β-[2-O- β-D- ガ ラ Network ト ピ ラ
ノ シ Le -3-O- (2-O- β-D- グ Le U ピ ラ ノ シ Le-α-L- ア ラ PVC ノ ピ ラ ノ シ Le)-β -
D- グ Le U ピ ラ ヌ ロ ノ シ Le オ キ シ] オ レ ア Na -12- エ Application -16 α, 22 α, 28- ト リ オ ー Le 22-
[(Z) -2- メ チ Le -2- Block テ ノ ア ー ト]) Tsubaki-saponin (Camelliasaponin) A1, as 3 β-[2-O- β -
D- galactopyranosyl glycosyls -3-O- (2-O- β-D- glucopyranosyl-α-L- arabopyranoses base)-β-D- glucopyra alditols
Acyloxy] olive -12- alkene -16 α, 22 α, 28- triols 22- [(E) -2- methyl-2-butenes acid esters] (3 β-[2-O- β -
D- ガ ラ Network ト ピ ラ ノ シ Le -3-O- (2-O- β-D- グ Le U ピ ラ ノ シ Le-α-L- ア ラ PVC ノ ピ ラ
ノ シ Le)-β-D- グ Le U ピ ラ ヌ ロ ノ シ Le オ キ シ) オ レ ア Na -12- エ Application -16 α, 22 α, 28- ト リ
オ ー Le 22- [(E) -2- メ チ Le -2- Block テ ノ ア ー ト]) Tsubaki-saponin (Camelliasaponin) A2, conduct
3 β-[2-O- β-D- galactopyranosyl glycosyls -3-O- (2-O- β-D- glucopyranosyl-α-L- arabopyranoses base)-β-D- pyrroles
Glucopyranoside aldehydic acid epoxide]-16 α, the α of 28- dihydroxies-22-[[(Z)-2- methyl-2-butenes acyl group] epoxide] olive-12- alkene-
23- aldehyde (3 β-[2-O- β-D- ガ ラ Network ト ピ ラ ノ シ Le -3-O- (2-O- β-D- グ Le U ピ ラ ノ シ
Le-α-L- ア ラ PVC ノ ピ ラ ノ シ Le)-β-D- グ Le U ピ ラ ヌ ロ ノ シ Le オ キ シ) -16 α, 28- ジ
ヒ De ロ キ シ -22 α-[[(Z) -2- メ チ Le -2- Block テ ノ イ Le] オ キ シ] オ レ ア Na -12- エ Application -
23- ア ー Le) Tsubaki-saponin (Camelliasaponin) B1, be used as 3 β-[2-O- β-D- galactopyranosyl glycosyl -3-O- (2-
O- β-D- glucopyranosyl-α-L- arabopyranoses base)-beta d glucopyranosiduronic acid epoxide] -16 α, 28- dihydroxies -22
α-[[(E) -2- methyl-2-butenes acyl group] epoxide] olive -12- alkene -23- aldehyde (3 β-[[2-O- β-D- ガ ラ Network ト ピ
ラ ノ シ Le -3-O- (2-O- β-D- グ Le U ピ ラ ノ シ Le-α-L- ア ラ PVC ノ ピ ラ ノ シ Le)-β -
D- グ Le U ピ ラ ヌ ロ ノ シ Le) オ キ シ] -16 α, 28- ジ ヒ De ロ キ シ -22 α-[[(E) -2- メ チ
Le -2- Block テ ノ イ Le] オ キ シ] オ レ ア Na -12- エ Application -23- ア ー Le) and Tsubaki-saponin
(Camelliasaponin) B2, as 3 β-[2-O- β-D- galactopyranosyl glycosyls -3-O- (2-O- β-D- glucopyranosyls-α -
L- arabopyranoses base)-beta d glucopyranosiduronic acid epoxide] olive -12- alkene -16 α, 22 α, 23,28- tetrols 22-
[(Z) -2- methyl-2-butenes acid esters] (3 β-[2-O- β-D- ガ ラ Network ト ピ ラ ノ シ Le -3-O- (2-O- β -
D- グ Le U ピ ラ ノ シ Le-α-L- ア ラ PVC ノ ピ ラ ノ シ Le)-β-D- グ Le U ピ ラ ヌ ロ ノ シ Le オ
キ シ] -16 テ ト ラ オ ー Le 22- [(Z) -2- メ チ Le -2- Block of α, 22 α, 23,28- of オ レ ア Na -12- エ Application
テ ノ ア ー ト]) Tsubaki-saponin (Camelliasaponin) C1 and be used as 3 β-[2-O- β-D- galactopyranosyl glycosyls -3-
O- (2-O- β-D- glucopyranosyl-α-L- arabopyranoses base)-beta d glucopyranosiduronic acid epoxide] olive -12-
Alkene -16 α, 22 α, 23,28- tetrols 22- [(E) -2- methyl-2-butenes acid esters] (3 β-[2-O- β-D- ガ ラ Network ト ピ ラ
ノ シ Le -3-O- (2-O- β-D- グ Le U ピ ラ ノ シ Le-α-L- ア ラ PVC ノ ピ ラ ノ シ Le)-β -
D- グ Le U ピ ラ ヌ ロ ノ シ Le オ キ シ] -16 テ ト ラ オ ー Le of α, 22 α, 23,28- of オ レ ア Na -12- エ Application
22- [(E) -2- メ チ Le -2- Block テ ノ ア ー ト]) Tsubaki-saponin (Camelliasaponin) C2 etc..In camellia
Distinguishingly contain these saponinses.
Also, it is originated according to the lipoic acid class of the present invention and species is not particularly limited, can be to ox or pig
The natural extract of the internal organs such as liver, or to such as ethene and adipate ester for the synthetic of initiation material, with public affairs
The material that the method known is taken, manufactured.Here, lipoic acid is due to asymmetric carbon atom, therefore there is optical property
Different mirror image isomers (R- enantiomers and S- enantiomers), but can be that any of the above is a kind of according to the lipoic acid of the present invention
Single enantiomer or above-mentioned enantiomer can also be racemic modification (racemic mixture with the mixture of arbitrary proportion
Or racemic compound) (RS- lipoic acids).When implementing in the industrial production, using it is cheap and be readily obtained it is commercially available
Racemic modification is relatively simple.Due to when using racemic modification when, make the tendency that the effect desired by the present invention preferably embodies compared with
Greatly, therefore racemic modification is preferably used.
The lipoic acid class used in the U.S. flesh accelerator of the present invention can suitably utilize each in addition to above-mentioned lipoic acid
Kind of derivative, be preferably by lipoic acid, its reduced form, their salt, their carboxylate, their acid amides and they
The material of one or more is selected in the group of cyclodextrin inclusion compound composition.
As the specific example of the reduced form of lipoic acid, can enumerate as:Dihydrolipoic acid (ジ ヒ De ロ チ オ Network ト acid),
Dihydrolipoic acid (ジ ヒ De ロ リ Port acid), 6,8- dimercapto octanoic acids, RS- dihydrolipoic acids etc..
As salt can enumerate as:LA, S- lipoic acids, RS- lipoic acids, R- dihydrolipoic acids, S- dihydrolipoic acids,
Sylvite, sodium salt, calcium salt, magnesium salts of RS- dihydrolipoic acids etc. etc..
As ester can enumerate as:Make LA, S- lipoic acids, RS- lipoic acids, R- dihydrolipoic acids, S- dihydro sulphur pungent
Acid, RS- dihydrolipoic acids etc. and polyalcohol (ethylene glycol, propane diols, butanediol, neopentyl glycol, glycerine, erythrol, polyglycereol
Deng monomer or polymer) formed partial esterification product complete esterification products or with glyceride type (monoglyceride, glycerine
Diester, triglycerides) or with carbon number for 10~22 higher alcohols (Decanol, laruyl alcohol, myristyl alcohol, cetanol,
N-octadecane alcohol, isooctadecane alcohol, behenyl alcohols etc.) monoesters etc. that is formed.
As acid amides can enumerate as:Make LA, S- lipoic acids, RS- lipoic acids, R- dihydrolipoic acids, S- dihydro sulphur
The acid amides of octanoic acid, RS- dihydrolipoic acids etc..
As cyclodextrin inclusion compound can enumerate as:α-, β-, γ-or δ-cyclodextrin and above-mentioned lipoic acid or its derivative
The inclusion compound that thing is formed.
It should be noted that the present invention is not limited to above example.
In the present invention, also included as lipoic acid class:From by above-mentioned lipoic acid, its reduced form, their salt, they
Carboxylate, their acid amides and they cyclodextrin inclusion compound composition group in select one or more crystallizations,
The outer surface of powder and/or particle by lipid coat formed by material, due to the form to the thermal metamorphism of lipoic acid class (point
Solution, polymerization, discoloration etc.), moisture absorption or oxidative deformation suppressed, therefore more preferred form from practicality.
The lipid of crystallization, powder and/or the particle external surface of above-mentioned lipoic acid class is coated, can utilize the present invention
Industrial field in allow the material that uses, additionally it is possible to general edible oil lipid or iundustrial oil lipid, fatty acid glycerine
Esters, fatty acid, fatty acid ester, fatty acid acyl amine, higher alcohols, wax class, steroid, sugared lipid, phospholipid
Deng being utilized alone or in combination.In material listed above, if it is considered that the operability of cladding and the physical property of coating are (stable
Property, curability, mobility, meltbility, dissolubility etc.), preferably fusing point is more than about 30 DEG C of lipid.More preferred form
It is the lipid that fusing point is about 40 DEG C~about 70 DEG C, further preferred form is the lipid that fusing point is about 40 DEG C~about 60 DEG C
Class.If below about 30 DEG C, having coating and the situation of solid-state being unable to maintain that when it is used, block is formed or damages flowing
Property situation occur., whereas if greater than about 70 DEG C, when manufacturing the inhibitor or composition according to the present invention, at heating
The influence of reason or mechanical energy, has the danger that lipoic acid class itself degenerates.
As the specific example of such lipid, can enumerate as:Soybean oil, rapeseed oil, corn oil, Semen Benincasae oil, cottonseed
Oil, wheat-germ oil, rice bran oil, sesame oil, olive oil, safflower oil, palm oil, palm kernel oil, coconut oil, linseed oil, peanut
The animal system grease of department of botany's grease, butter, lard, the fish oil of oil etc. etc., above grease is applied with point carry, it is ester exchange, de-
The processing grease of one or more of the processing of color, deodorization etc., each of partially or completely hydrotreating is carried out to above grease
Plant saturated fatty acid (acetic acid, butyric acid, caproic acid, octanoic acid, capric acid, laurate, nutmeg that fixed oil, carbon number are 2~22
Acid, pentadecanoic acid, palmitic acid, stearic acid, 12- hydroxy stearic acids, isostearic acid, arachidic acid, behenic acid etc.) or unsaturated fat
Sour (palmitoleic acid, oleic acid, linoleic acid, alpha-linolenic acid gamma-Linolenic acid, castor oil acid, arachic acid, eicosapentaenoic acid
(EPA), erucic acid, docosahexaenoic acid (DHA) etc.), salt (sodium salt, sylvite, calcium salt, the magnesium salts of any of the above aliphatic acid
Deng), with monohydric alcohol (methanol, ethanol, propyl alcohol, butanol etc.) formation esters, with polyalcohol (ethylene glycol, propane diols, butanediol,
The polymer of the non-monomer of neopentyl glycol, glycerine, erythrol, polyglycereol etc.) formed partial esterification product or completely esterification
Product or glyceride type (monoglyceride, diglyceride, triglycerides) or with carbon number for 10~22 higher alcohols (just
Decyl alcohol, laruyl alcohol, myristyl alcohol, cetanol, n-octadecane alcohol, isooctadecane alcohol, behenyl alcohols etc.), wax class (Zong Beam-at-the-eaves waxes, rice wax
The wax from plant of (rice bran wax), candelila wax etc., beeswax, spermaceti, shellac wax etc. derive from the wax of animal, paraffin, micro-
Brilliant wax etc. derives from the wax of oil, the wax from mineral of lignite wax, ceresine etc., Tissuemat E, above-mentioned fatty acid and on
State the synthetic wax of the ester etc. of higher alcohols formation), steroid (cholesterol of animality, vegetal campesterol, stigmasterol,
Sitosterol etc., ergosterol, their derivative from mushroom), sugared lipid (monosaccharide groups diglyceride (モ ノ グ Le
U シ Le ジ グ リ セ リ De), monogalactosyl diglyceride, disaccharide base monoglyceride (ジ グ Le U シ Le モ ノ グ リ セ リ De),
Double galactolipin monoglycerides (ジ ガ ラ Network ト シ Le モ ノ グ リ セ リ De), monosaccharide groups diglyceride, digalactosyl diglyceride,
Sucrose fatty ester etc.).It should be noted that the present invention is not the invention limited by above-mentioned example.
Any one or two or more mixtures of above-mentioned various lipids can be used in the present invention, it is preferable that
The species of lipid is above-mentioned edible oil lipid or iundustrial oil lipid, fatty acid glycerine esters, fatty acid ester and wax
Class, more preferably edible oil lipid and fatty acid glycerine lipid, also, fusing point adjustment from cladding lipid, coating film
From the viewpoint of reinforcing etc., be more preferably them with from fatty acid, higher alcohols, steroid, sugared lipid or Phospholipids
The form that the one or more kinds of materials selected in class are combined.
Using known method the outer surface of crystallization, powder and/or the particle of lipoic acid class can be made to be coated by lipid.
I.e., it is possible to be following methods:Using ball mill, scouring type mixer (bulk material mixer), V-Mixer, high-speed mixer,
High speed paddle mixer, heating melting mixing machine, ultrasonic wave overly moist liquid adding type mixer, barrel mixer, pressurization extruder
Deng making crystallization, powder and/or the particle of lipoic acid class uniformly mix, cool down with the lipid of heating melting and make after it solidifies
The method crushed;To carry out the liquefied lipid after suitable heating spraying or drippage and to the lipoic acid of above-mentioned form
The method that class is coated;The lipoic acid class of above-mentioned form is carried out into high-speed stirred with the lipid of particle shape mixes it, leads to
Crossing makes both contact or collide so that the lipid of particle shape is uniformly attached to crystallization, powder and/or the particle of lipoic acid class
Integral surface and the method coated.In the present invention, in the above method be preferably, by the crystallization of lipoic acid class, powder and/
Or particle carries out high-speed stirred with particle shape lipid more than above-mentioned specific fusing point and mixes it, by making both contact or touch
Hit so that the lipid of particle shape is evenly coated at the method on the integral surface of the lipoic acid class of above-mentioned form.
When carrying out above-mentioned cladding processing, according to the shape or size of the crystallization of lipoic acid class, powder and particle, lipid
Species and fusing point, the thickness of coating film and character etc. factor, it is difficult to by the crystallization of lipoic acid class, powder and/or particle with
The ratio regulation of lipid is consistent, but generally, for crystallization, powder and/or the particle of the lipoic acid class of 1 mass parts, lipid
Class is the mass parts of about 0.05 mass parts~about 10, the mass parts of preferably from about 0.1 mass parts~about 5.If lipid is less than about
0.05 mass parts, coated state is insufficient and is difficult to embody desired effect;, whereas if more than about 10 mass parts, cladding
Lipoic acid content in thing is few, is limited in the case of using coating by fit rate etc. and occurs and damage practical value
Situation.
Here, the coating of the lipid by above-mentioned lipoic acid class, with being applied to beverage etc. with the presence or absence of by it
Situation in water system composition is unrelated, still more preferably to make its outer surface coat formed form by close substances in aquatic system
Material.Here, described close substances in aquatic system refers to, the further outer surface of coating of the cladding from lipid, can be formed and
Aqueous substance has the material for being wrapped by film of compatibility, can enumerate as a specific example as:Polysaccharide (xanthans, cluster bean
Glue, tamarind gum, plantasan etc.), starch and chemical starch, yeast cell wall component, glucose, mannosan, shellac, sea
Mosanom, gelatin, carragheen, amylopectin, carboxymethyl cellulose, soybean protein, lactalbumin, zein etc..It is more excellent
Elect as from polysaccharide, starch, yeast cell wall component, shellac, gelatin, soybean protein, zein and mannosan composition
Group in select one or more kinds of;The group more preferably constituted from yeast cell wall component, shellac and gelatin
Middle selection is one or more kinds of.
, can be using the method for coating according to above-mentioned lipid when being coated by related close substances in aquatic system
Method.That is, above-mentioned close substances in aquatic system is suitably dissolved in water, ethanol, other solvents and form liquid material, be attached to it pre-
First coated by lipid lipoic acid class outer surface, dry after can form the coating film of close substances in aquatic system.Related cladding
Thing formation is being used in diet product, feed, cosmetics, doctor using close substances in aquatic system as outermost dual cladding structure
In the case of medicine etc., the compatibility with aqueous raw material or composition is improved, can be easily low by them and water-soluble
Lipoic acid class is formulated as homogeneous composition.
The lipid from lipoic acid class as described above coating and make the coating further by hydrophilic system
In the dual cladding thing of material cladding, by the way that it coexists in them and with following substances, it can further suppress sulphur
The heat of sad class and/or denaturation or the variation of oxidation, obtain the coating of the lipoic acid class of excellent in stability, therefore in this hair
The lipoic acid class of more preferred relevant form in bright, above-mentioned substance is:From HCA pericarp, red rattletop rhizome, Guava Leaf and
Their extract (passes through water and/or extract, its point of hydrophilic organic solvent (low-grade monobasic alcohol such as ethanol, acetone etc.)
Level thing or solvent fraction leach-s/tive or refined thing etc.), select one or more kinds of in the group of carnitine composition, it is more preferably red
The extract and carnitine of rattletop rhizome, most preferably carnitine.
The coating of foregoing lipoic acid class is set to contain above-mentioned and be in following form with the form of raw material
The combination of any one or these forms, i.e.,:(i) make lipid be coated on the crystallization of lipoic acid class, powder and/
Or mixed in the coating on particle it is above-mentioned and with raw material, (ii) by the crystallization of lipoic acid class, powder and/or particle with it is above-mentioned
And carried out coating lipid, (iii) bag on the crystallization of lipoic acid class, powder and/or particle on mixed material with raw material
Be covered with state and do not disperseed with a part for raw material and make its dissolve lipid, (iv) the crystallization of lipoic acid class, powder and/
Or attachment is coated on the coating of lipid on particle and with lysate, dispersion liquid or the emulsification of raw material and above-mentioned close substances in aquatic system
Liquid and drying and coated.In the present invention, (i) and (iv) form reach the effect of the present invention, manufacture simplicity, coating
Use good operability, still (i) and (iii) form be easy to embody more potent desired effect.
In related form, coated on the crystallization of lipoic acid class, powder and/or particle lipid or lipid and
The coating of close substances in aquatic system with it is above-mentioned and with the mixed proportion of raw material be:Relative to the mass parts of coating 1, it is above-mentioned and
Raw material is about 0.01~about 10 mass parts, even more preferably about 0.1~about 1 mass parts.In the case of less than about 0.01 mass parts,
Can not approve can obtain the raising of desired effect by mixing and with raw material;In the case of more than about 10 mass parts,
In above-mentioned coating, reduced especially with the lipoic acid content in its composition, and then cooperation can be limited and contain lipoic acid
Lipoic acid content in the various products of based composition, the desired effect of lipoic acid itself can not be expected in the product stage
Really.
Can be known organic chemistry according to the source of the resveratrol class of the present invention or species and unspecific material
Method or be the material taken, manufactured using microorganism or yeast etc., it is preferred that for from Vitaceae, polygonaceae or beans
The material that the position of pericarp, stem, leaf, climing, sprouting, seed, flower, the fruit of the plant of section etc. etc. is extracted and obtained.
As the source of the resveratrol class according to the present invention, more preferred plant is the plant of Vitaceae Vitis,
The kind that its kind is not particularly limited to, but can for example enumerate as:A Yilun, Aligote, Wa get Qi, Viognier, Weir are different
Riesling, Ao Tejia, Cabernet Sauvignon, Cabernet franc, Jiamei, beauty's wine, karr Ka Naika, Jiamei's Na, western sieve Norma, green Wei Teli
Receive, Traminer, treasure take, Jia state, song rumba, refreshing rope, holy Glan Dinon, Sangiovese, YveSsaintLaurent, Sha Sila, Chardonnay, Bai Shi
South, Shi Aibo, Semillon, Sauvignon Blanc, Dynaudio, Ci Weige, pellet soul, Ta Mingna, cut piece more, it is the red, Mo Niyepinuo of red phenanthrene, general
Sa, Furmint, blue brier grape tooth people, Moschus, Ma Er Visas, Ma Erbaike, mousse card moral, Miller-Tours height, curtain Wei get Er,
U.S. Gansu Province, Mario mousse Ka Te, Maas card fourth, admire fondly grape, peace rue queen consort, Vidal Blanc, Ju Feng, Momotaro grape, Su Weiweng
In vain (セ イ ヴ ァ Le Block ラ Application), Di Lawa, Niagara, new Moschus, Hei Bake, Bai Bake, Pi Aonai, bud rose,
Rattan is harvested, Rome ruby, Jia Fei roads, the chi of Jia state three etc..They can be suitably utilized in Chile, Japan, Italy, France etc.
The grape that ground grows or cultivated naturally, can be extracted from each position of the kind of above-mentioned example, more preferably from stem, climing, sprouting
Or spend middle extraction.
It can be manufactured according to the resveratrol class of the present invention by any means, but can be any one in following substances
Kind:That is, be dried, chop up using the stem of grape of above-mentioned example, climing, sprouting or flower itself or by them, pulverization process
Material, and Extraction solvent during it is impregnated into the scheduled time in a solvent or makes it and is heated to reflux contacts and extracted
Liquid, will from the extract solution remove solvent extract, to the extract carry out using silica gel, magnesium silicate, ion exchange resin,
The refined thing for the refinement treatment that the column chromatography or solvent of the adsorbent of activated alumina, cellulose, activated carbon etc. point are carried etc. and
By these materials by method powdereds such as freeze-dried, spray drying.In the case of being used in food applications, from convenience
From the viewpoint of manufacturing cost, be preferably, the position of above-mentioned plant is dried and suitably crushing after powder, by water
Or hydrophilic organic solvent in small, broken bits of the dried object or powder are extracted after extract.Also, it is being used in doctor
In the case of pharmaceutical product use, the preferably refined thing of said extracted liquid, extract or high-purity.
As hydrophilic organic solvent can enumerate as:The low-grade monobasic alcohol class of methanol, ethanol, normal propyl alcohol, isopropanol etc., third
The polyalcohols of glycol, 1,3-BDO, glycerine etc., acetone, methyl ethyl ketone, ether, petroleum ether, ethyl acetate and it
Hydrate or mixture.The extract for producing the effect desired by the present invention is being efficiently obtained, is being preferably by second
Alcohol, acetone, ethyl acetate and their hydrate are used as extraction solvent.To the moisture of hydrate, for example, in ethanol
In the case of, it is about 1~about 99 mass %, even more preferably about below 50 mass %;It is about 1~about 50 in the case of acetone
Quality %, even more preferably about 10~about 30 mass %;It is about 80~about 99 mass %, more preferably in the case of ethyl acetate
It is about 85~about 95 mass %.If departing from above range, the effect desired by the present invention can be reduced or the production of extract is reduced
Amount.
According to the resveratrol class of the present invention using following compound as object, i.e. the trans-resveratrol (list of resveratrol
Body) or ε-grape element (dimer), the polymer and their isomers and/or glucoside of going back age polyphenol (tripolymer) etc.
Deng stilbene compound.Here, from the situation of the extract obtained by above-mentioned plant be using above-mentioned stilbene compound as main
Active component, have comprising Quercetin, Ellagitannins, ellagic acid, mineral substance (such as potassium, calcium, phosphorus, magnesium), vitamin class situation.
In the U.S. flesh accelerator of the present invention, with collagen peptide and the content of improving blood flow agent be U.S. flesh promotion
Agent all about 0.01~about 50 mass %, preferably from about 0.1~about 20 mass %, more preferably about 0.5~about 10 matter
Measure %.If below about 0.01 mass %, and the effect caused by is small, conversely, the use more than about 50 mass % can not yet
Expect preferably desired effect.It should be noted that improving blood flow agent can use above-mentioned public affairs alone or in combination and arbitrarily
The material or extract known, it is preferred that from camellia seed extract, lipoic acid class, resveratrol class and to contain resveratrol
The one or more selected in the plant extracts of class, more preferably comprising all above-mentioned substances.By camellia
Among seed extract, lipoic acid class, resveratrol class and plant extracts containing resveratrol class it is two or more together
Ratio (quality criteria) in the case of use is substantially:Camellia seed extract/lipoic acid class is 20/80~30/70, more excellent
Elect 60/40~40/60 as;Camellia seed extract/resveratrol class is 99/1~30/70, more preferably 80/20~50/50;
Lipoic acid class/resveratrol class is 99/1~30/70, more preferably 80/20~50/50;Also, to camellia seed extract/
Lipoic acid class/resveratrol class, the ratio of respective improving blood flow agent is more than the about 1 mass % of the total amount of U.S. flesh accelerator, more
Plus be preferably to contain more than about 10 mass %.It should be noted that in the case of the plant extracts containing resveratrol class,
It is contemplated that the content of resveratrol class in the extract and set.
Above-mentioned U.S. flesh accelerator with collagen peptide and improving blood flow agent (particularly from camellia seed extract, lipoic acid class,
The one or more selected in resveratrol class and the plant extracts for containing resveratrol class) and use thing conduct
Active ingredient, can directly be used, i.e. form the powdered, solid-like being only made up of above-mentioned active ingredient, pasty state or liquid
Form, in the purposes for being used in diet product, pharmaceuticals, non-pharmaceutical products, feed etc..
The U.S. flesh accelerator of the present invention, can also suitably and use can utilize known in its such use add
Thing, makes it contain and be utilized as composition for oral administration by conventional method.Here, known additive can be in order to
Orally ingestible and usually used material, for example, excipient, bonding agent, disintegrant, mixed lubrication prescription, wetting agent, fluidisation can be used
Agent, preservative agent, surfactant, stabilizer, diluent, lytic agent, tonicity agent, bactericide, preservative, flavouring, flavoring agent,
The additive of colouring agent, spices etc..Further, the material described in above-mentioned prior art literature is not limited to, also may be used
To be used in combination with the principal component or the raw material containing the composition that are acted on U.S. flesh and/or improving blood flow is acted on.U.S. of the present invention
Flesh accelerator is also used as the cooperation original of diet product, pharmaceuticals, non-pharmaceutical products, feed, the various products of other industrial fields
A part for material and used.It is particularly preferred that being used as the product for beauty etc..
In the case of using U.S. flesh accelerator and the known additive of the present invention and with and as composition for oral administration
Form, can be the preparations for oral administration of the type for powder agent, granule, tablet, capsule, liquor etc..According to and use raw material
Species or content etc. factor, it is difficult to the content to the above-mentioned active ingredient in related composition for oral administration provides consistent,
But substantially 0.1~100 mass % or so, more preferably about 10~about 100 mass % or so.If above-mentioned content is below about
0.1 mass %, will be unable to accreditation desired effect of the invention.The U.S. flesh accelerator of the present invention passes through orally ingestible or administration
Method is utilized.The benchmark of the suitable intake of composition for oral administration of the invention in this case or administration amount is:With
Based on the above-mentioned active ingredient contained in the agent, the daily about 100mg~about 100000mg of adult (body weight 50kg) is preferably
About 500mg~about 10000mg, more preferably about 1000mg~about 5000mg.
The present invention U.S. flesh accelerator can as diet product, pharmaceuticals, non-pharmaceutical products, feed etc. known production
A part for the cooperation raw material of product and utilized.Practical product is described below, but the present invention is not by this
Any limitation of example.
As the specific example of diet product, can enumerate as:The beverage class of vegetable juice, fruit drink, cold drink, tea etc.;
The snack categories of cake ready mix product, bread, cake, chocolate, candy, chewing gum, chewing gum etc.;Miso, soy sauce, sauce, egg
The flavoring of yellow bean sauce, barbecue or flour juice etc.;The noodles of instant noodles, Noodle, buckwheat, pasta etc.;Ham or sausage etc.
Poultry meat the flesh of fish processed food;The powdered of milk, Yoghourt, cream, butter, taste product or cheese etc., solid-like or liquid
Dairy products;Seasoned food, hamburger, Deep-fried meatballs, the seafood delights being sprinkling upon on rice are cooked, jam, jelly, pudding, salad dressing, plant
Property the various general processed foods that drench etc. of cream, Mai Qi, in addition also powdered, graininess, pill shape, tablet shape, soft
Capsule shape, ebonite cryptomere, pasty state or liquid dietary supplement, specific health treatment, functional food, healthy food,
Treatment food of high density liquid food or aphetite disorder food etc..
When manufacturing these diet products, the U.S. flesh accelerator of the present invention and known raw material can be used, or pass through this
A part for the known raw material of U.S. flesh accelerator displacement of invention, is manufactured according to conventional method.For example, as needed
By the figuration of U.S. flesh accelerator and the blood glucose of the present invention, glucose, dextrin, lactose, starch or its machining object, cellulose powder etc.
Agent, vitamin class, mineral substance, the grease of animals and plants or fish and shellfish, albumen (including protein from animals and plants or yeast,
Its hydrolyzable thing etc.), saccharic, pigment, spices, antioxidant, surfactant, other food additives, contain various battalion
The edible material for supporting the powder or extracting species of functional component etc. is mixed together and is processed as powder, particle, pasty state, tablet etc.
Shape, or the form of the general processed food of above-mentioned example is processed as by conventional method, or pass through gelatin, sodium alginate, carboxylic
The covering of sodium carboxymethylcellulose pyce etc. is coated to the powder or liquid material of mixing and forms capsule or be processed as beverage (drink
Category) form, utilized preferably as dietary supplement or healthy food.Be particularly preferably tablet, capsule,
The form of potus.It should be noted that the content or intake of the U.S. flesh accelerator of the invention contained in these diet products with
The situation of above-mentioned composition for oral administration is roughly the same.
To the pharmaceuticals and non-pharmaceutical products of the U.S. flesh accelerator using the present invention, the technology of the present invention thought can not violated
In the range of the known excipient or additive that pharmaceutically allow are added in above-mentioned oral U.S. flesh accelerator, pass through general side
Method is processed and the preparation of piece agent, capsule, granule, pulvis, liquor etc..By oral suitable for prevention or treatment
Dry, elastic reduction, pachylosis etc..It should be noted that the U.S. of the invention contained in these pharmaceuticals and non-pharmaceutical products
Situation of the content or intake of flesh accelerator according to above-mentioned composition for oral administration.
Also, when making the U.S. flesh accelerator of the present invention suitable for pet food or livestock feed, with above-mentioned diet
The situation of product is identical, may be fitted in known all feeds or drinking water, or adds together with known raw material, additive
Work is the dosage form of tablet shape, graininess, capsule shape etc..The content for the U.S. flesh accelerator of the invention contained in these feeds
Or intake is roughly the same with the situation of above-mentioned composition for oral administration.
Embodiment
Then, enumerate embodiment the present invention is described in detail, but the present invention is not appointed by these embodiments
What is limited.In each example, %, part and ratio are marked except non-specifically, are quality criteria.
Production Example 1 (collagen peptide (1))
Added in the skin 1kg of the body of catfish and bone is eliminated under 5L water, normal pressure, be heated to after 85 DEG C appropriate stirring 1
Individual hour and extract gelatin.Gelatin solution is cooled to 50 DEG C, protein decomposition enzyme is added, 2 hour enzyme reactions are carried out.So
Afterwards, inactivate enzyme, separating filtrate after filtering.The lower concentration filtrate of decompression, carries out freeze-dried and crushes, obtain 192g collagens
Peptide (sample 1).HPLC analyses are carried out to the collagen peptide by conventional method, mean molecule quantity is about 1000.
Production Example 2 (collagen peptide (2))
It is net with massive laundering after being handled by 0.1N hydrochloric acid the squama of Tilapia mossambica, dry its sunshine.In drying
Squama 1kg in add 8L water, under normal pressure, be heated to after 85 DEG C suitably stir 1 hour and extract gelatin.Gelatin solution is cooled down
To 50 DEG C, protein decomposition enzyme is added, 1 hour enzyme reaction is carried out.Then, inactivate enzyme, separating filtrate after filtering.Under decompression
Filtrate is concentrated, carries out freeze-dried and crushes, 711g collagen peptides (sample 2) are obtained.By conventional method to the collagen egg
White peptide carries out HPLC analyses, and mean molecule quantity is about 5000.
Production Example 3 (camellia seed extract (1))
The dry seed that the shallow lake overgrown with wild plants Chinese toon on her Dou great islands will be originated in is carried out after coarse crushing boiling, and progress, which is squeezed, has been separated squeezing
The squeezing dregs of rice of oil.Added in degreasing thing 1kg under 3L water, normal pressure, be heated to after 85 DEG C suitably stir after 1 hour, cooled down
To room temperature, separating filtrate after filtering.Add after 1L water and carry out after identical heating, stirring, cooling again in the filtering residue,
Filtered and take filtrate.Will two kinds of filtrates merge after be concentrated under reduced pressure, freeze-dried and crushing, obtain by water solubility into
Powdered camellia seed extract (sample 3) 170g being grouped.HPLC analyses are carried out to the extract by conventional method, should
Extract contains 7.5% Camelliasaponin B2,5.8% Tsubaki-saponin C2, a kind of 2.4% Kaempferol as flavonoids.
Production Example 4 (camellia seed extract (2))
2L hydrous ethanols (moisture content 35%) are added in progress and degreasing thing 1kg obtained from the same treatment of Production Example 3,
It is heated to reflux at 80 DEG C after 1 hour, is cooled to separating filtrate after room temperature, filtering.2L is added again in the filtering residue
Hydrous ethanol (moisture content 35%) is carried out after identical heating, cooling afterwards, is filtered and takes filtrate.Two kinds of filtrates are merged
Concentrated under reduced pressure afterwards, after freeze-dried and crushing, obtain powder (sample 4) 12.1g of containing water-soluble composition.To the powder
End carries out the result after being analyzed with the identical HPLC of Production Example 3:Containing 8.3% Camelliasaponin B2,5.9% Tsubaki-saponin C2,
A kind of 2.6% Kaempferol as flavonoids.
Production Example 5 (the lipid coating of lipoic acid)
In lipoic acid (German Lai Yu companies (the De イ Star ア ルツケム societies) production, commodity of 330g crystalline powder
Name:ALIPURE (registration mark), racemic modification) in add heating melting 200g hydrogenated rapeseed oils (river grind fine chemistry strain
Formula commercial firm (grinding Off ァ イ Application ケ ミ カ Le (strain) in river) produces, fusing point:67 DEG C, sheet), it is sufficiently mixed and makes after it is uniformly dispersed,
Solidification is allowed to cool at room temperature.Then, the solidfied material is crushed by homogenizer, passes through 100 mesh (taylor criteria net
It is eye, same as below) sieved after to obtain particle diameter be less than 150 μm of lipoic acid lipid coating (sample 5).
Production Example 6 (cyclodextrin inclusion compound of lipoic acid)
Make lipoic acid (German Lai Yu companies (the De イ Star ア ルツケム societies) production, commodity of 100g crystalline powder
Name:ALIPURE (registration mark), racemic modification) dissolved in 50% ethanol 500mL, add 800g alpha-cyclodextrin (Germany
Wacker Chemical Co., Ltd (De イ Star ワ ッ カ ー ヘ ミ ー societies) produces, trade name:CAVAMAX (registration mark), (R) W6), suitably
After stirring, make its concentration, spray drying, obtain lipoic acid cyclodextrin inclusion compound (sample 6).
Production Example 7 (resveratrol extract)
The sunshine dried object 500g of the stem of grape (Cabernet Sauvignon) is carried out after refluxing extraction by 2L 70% ethanol solution,
Filtered and separating filtrate.70% ethanol for adding 1L again in the filtering residue carries out refluxing extraction, is filtered
And separating filtrate.Concentrated under reduced pressure after two kinds of filtrates are merged, be spray-dried, obtained after adding dextrin wherein
24g resveratrol extracts (sample 7).It is by the result that the powder is carried out after HPLC analyses by conventional method:Contain 6.2%
Trans-resveratrol, 6.0% ε-grape element.
Experimental example 1 (improving blood flow effect)
The subject 40 (24~65 years old, male 20, women 20) of participation experiment as described below will be obtained agreeing to
It is grouped according to 5 one group, measuring of blood flow experiment is carried out according to double blind check method.First, subject is made to enter control temperature
Spend for 24 ± 2 DEG C, the constant temperature and humidity room that humidity is 50 ± 10%, peace and quiet wait 10 minutes.Afterwards, using Laser doppler seanning
(lark prestige company (Perimed societies) is produced, PeriScan PIMII) determines the CBF of the back of the hand before absorbing experiment sample.
Then, allowed in control group (placebo) testee with 100mL water absorb together be colored as subject can not root
The hard shell capsules of dextrin are filled with the hard shell capsules (gelatin system, same as below) differentiated according to color, allowed in other groups by reality
The person of testing absorbs the hard shell capsules that each experiment sample is filled with the hard shell capsules of above-mentioned same colored with 100mL water together, at 30 points
Zhong Hou, carry out measure same as described above after 60 minutes to the CBF of the back of the hand again.It should be noted that by above-mentioned camellia seed
Extract (sample 3, sample 4), commercially available lipoic acid, lipoic acid lipid coating (sample 5), resveratrol extract (sample
7), (ball is apt to for commercially available ginkgo biloba p.e (You Ma biotech companies (PVC ー エ イ チ エ ヌ (strain)) production) and panax ginseng extractum
Pharmaceutical Co., Ltd's (Wan Shan System medicines (strain)) production) as experiment sample.
The result is as shown in table 1.In the table, numerical value be using absorb placebo and by the value before Test Materials as
Relative value when 100, is indicated (n=5, ANOVA are analyzed) by average value ± standard deviation.From the data of table 1, it is impossible to recognize
For the back of the hand and the CBF significant changes of scalp of the subject that intake of placebo, but it intake of sample 3 or sample 4
The situation of (camellia seed extract), lipoic acid or sample 5 (lipoic acid lipid coating) and sample 7 (resveratrol extract)
Under, blood flow facilitation and ginkgo biloba p.e is intake of or the situation of panax ginseng extractum reaches same degree, after intake 30 minutes
And two times after 60 minutes, confirm that the value of the CBF of the back of the hand is significantly increased.
【Table 1】
Table 1 promotes the blood flow of the back of the hand the influence of (CBF)
Experimental example 2 (skin fiber sprout cell Effect of promoting growth)
The influence of the propagation to skin fiber sprout cell is investigated by the following method.That is, using Petri dishIn 10% fetal bovine serum of addition D-MEM culture mediums (SIGMA company (シ グ マ societies) produces, hypoglycemia)
The adult skin fiber sprout cell of sowing normal person in (Daiichi Pure Chemicals Co., Ltd.'s (the first chemicals (strain)) production)
(Kurashiki Boseki K.K. (Network ラ ボ ウ (strain)) produces, NHDF (NB).Hereinafter referred merely to as cell.)2×105It is individual, cultivate 4 days
To becoming closely to converge (about 80% density).Then, culture medium is removed, then is passed through by 5mL PBS cell twice
After 0.02% EDTA solution 5mL cleaning cells, with 0.25% trypsin solution (NACALAI TESQUE Co., Ltd.
(Na カ ラ イ テ ス Network (strain)) is produced) 5mL recovery cells, centrifuge (4 DEG C, 1000rpm, 5 minutes) and remove supernatant afterwards, lead to
Cell is obtained after crossing PBS 2 times.The cell is cultivated repeatedly under these conditions and carries out squamous subculture.
Use 96 porocyte culture plates (0.32cm2, Asahi Glass Co., Ltd (rising sun テ Network ノ グ ラ ス (strain)) production),
With low blood serum medium, (Kurashiki Boseki K.K. (Network ラ ボ ウ (strain)) produces application on human skin fiber sprout cell propagation, in 500mL
Skin fiber sprout cell basal medium (106S) in the addition of 10mL low serum propagation additive (LSGS) culture medium)
Middle sowing 1 × 104The above-mentioned squamous subculture cell in individual/hole, cultivates 24 hours.Then, culture medium is removed, is made most with the addition of
The above-mentioned application on human skin fiber sprout cell propagation of the μ g/mL of final concentration of 5,10 or 20 each sample is further continued for training with low blood serum medium
48 hours are supported, afterwards, adding MTT solution (makes Thiazolyl blue (SIGMA company (シ グ マ societies) produces, reagent) be dissolved in PBS
It is 5mg/mL to concentration) 25 μ L, 1 hour of culture.After by being decanted and removing culture medium completely, 100 μ L formazan solution are added
(include 25% (v/v) 0.45M hac buffers, 25% (v/v) N,N-dimethylformamide, 10% (w/v) dodecyl sulphur
Sour sodium.PH value is 4.5) to be stirred.Place at room temperature after 1 night, determine the absorbance in 590nm, evaluate the propagation journey of cell
Degree.It should be noted that in the above-mentioned methods, D-MEM culture mediums and application on human skin fiber sprout cell propagation use low blood serum medium
It is as the culture medium that with the addition of penicillin (ultimate density 100IU/mL) and streptomysin (ultimate density 0.1mg/mL), cell training
Support in CO2gas incubator (37 DEG C, 5%CO2Reinforcing gas phase under) in carry out.Here, above-mentioned collagen peptide (is tried
Material 1, sample 2), camellia seed extract (sample 3, sample 4), commercially available lipoic acid, lipoic acid lipid coating (sample 5), sulphur
The cyclodextrin inclusion compound (sample 6) of octanoic acid, resveratrol extract (sample 7), commercially available ginkgo biloba p.e (the biological skill of excellent horse
Art company (ビ ー エ イ チ エ ヌ (strain)) production), carrot extract (Maruzen Pharmaceuticals Co., Ltd.'s (Wan Shan System medicines (strain)) it is raw
Production) and sample 1 or sample 2 be used together with each sample as experiment sample.
The result is as shown in table 2, table 3, table 4.In the table, numerical value by with simultaneously implement check experiment (without
In the case of sample) value represented as relative value when 100.In table 2, the ultimate density of sample 1 and sample 2 for 50 and
100 μ g/mL, also, by the addition of other samples in the medium, it is 5 and 10 μ g/mL to make ultimate density.In table 3 and table 4, with
Sample 1 and sample 2 are 50 μ g/mL, and other samples are respectively added to 5 μ g/mL in the medium.
It is also considered as simultaneously in each addition concentration from the data of table 2, each sample makes the effect that skin fiber sprout cell breeds
It is weak.
Also, from the data of table 3, in the case of sample 3~7 and lipoic acid are used together in sample 1, synergistically make fibre
The effect of dimension sprout cell propagation becomes obvious.By being further used together sample 1 and sample 3, sample 7 and lipoic acid, the increasing
Growing effect is strengthened.But, to ginkgo biloba p.e and carrot extract, it is impossible to confirm to improve the propagation of fiber sprout cell
Effect.
From the data of table 4, also confirm to improve the effect of the propagation of fiber sprout cell, but it is believed that with the data of table 3
Situation is compared, and the cultivation effect has the tendency of low.
It should be noted that being carried out instead of sample 1 or sample 2 using the collagen peptide that mean molecule quantity is about 300
Same experimental result is:It is with the tendency of the data of table 3 etc. that fiber sprout cell according to thing is used together, which breeds facilitation effect,
It is same or higher (omitted data).
【Table 2】
Influence of each sample of table 2 to the propagation of skin fiber sprout cell
【Table 3】
Influence of the combination of table 3 and sample 1 to the propagation of fiber sprout cell
With sample 1 and sample | Absorbance (590nm) |
Control | 100±3 |
Sample 3 | 127±8 |
Sample 4 | 125±9 |
Sample 5 | 120±3 |
Sample 6 | 121±4 |
Sample 7 | 122±7 |
Lipoic acid | 122±2 |
Ginkgo biloba p.e | 105±1 |
Panax ginseng extractum | 106±3 |
Sample 3+ lipoic acids | 146±8 |
Sample 3+ samples 7 | 143±8 |
Lipoic acid+sample 7 | 141±8 |
Sample 3+ lipoic acids+sample 7 | 161±8 |
【Table 4】
Influence of the combination of table 4 and sample 2 to the propagation of fiber sprout cell
With sample 2 and sample | Absorbance (590nm) |
Control | 100±3 |
Sample 3 | 118±4 |
Sample 4 | 117±6 |
Sample 5 | 113±4 |
Sample 6 | 114±2 |
Sample 7 | 111±5 |
Lipoic acid | 116±5 |
Ginkgo biloba p.e | 104±3 |
Panax ginseng extractum | 104±3 |
Sample 3+ lipoic acids | 136±6 |
Sample 3+ samples 7 | 132±9 |
Lipoic acid+sample 7 | 128±5 |
Sample 3+ lipoic acids+sample 7 | 140±9 |
By above content, it specify that the combination according to collagen peptide of the invention and improving blood flow agent, particularly lead to
Crossing Camellia extract, lipoic acid class, resveratrol has the effect of the significant propagation for promoting application on human skin fiber sprout cell.
Herein, although eliminate experimental data, but in this experimental example, by sample 1 or sample 2 and above-mentioned three kinds of blood
Flow improvement result composition and situation compared with the situation for individually using it, it is thus identified that it is thin by application on human skin fibrous bud
The ability of the generation collagen of born of the same parents and the ability of generation hyaluronic acid are significantly improved.
Experimental example 3 (is tested) to the U.S. flesh of people
It will obtain agreeing to participate in experiment as described below and skin elasticity and the low volunteer adult female 60 of amount of moisture
(35 years old~55 years old, average age:48.6 years old), separated by 51 group, each group is absorbed each sample respectively, continued 6 weeks.
Absorb sample front and rear with skin determination of viscoelasticity device (Germany, CK companies (Courage+Khazaka societies), trade name:
CUTOMETER MPA580 (R)) skin elasticity is measured, also, the moisture of the predetermined position of face is filled with determination of moisture
Put (Corneometer (R) CM825) and determine moisture relative value.It should be noted that this experiment is with above-mentioned sample 1, sample 3, examination
Material 7, lipoic acid and combinations thereof, ginkgo biloba p.e same as described above and carry out.Intake is:Sample 1 is 5g, except this
Sample in addition is 200mg, and in the case where being combined with sample 1, sample 1 is 5g, made together with sample 200mg in addition
With.
The result is as shown in table 5.Skin elasticity and amount of moisture before and after sample intake are:It intake of except ginkgo leaf is extracted
In the case of each sample beyond thing, compared with before intake, discovery has some improvement results after intake, but with absorbing preceding phase
Than without big difference.But, in the case where being respectively combined with sample 1, skin elasticity and amount of moisture are substantially improved, clearly
According to the combination of the collagen peptide of the present invention and improving blood flow agent, especially by with Camellia extract, lipoic acid class, white
Veratryl alcohol is used together promotes U.S. flesh effect with significant.
【Table 5】
Influence (mean+/-standard error) of the table 5 to the skin of people
Study example 1 (soft capsule)
In above-mentioned sample 1 and the (mixing ratio of sample 3:10/1), sample 1 and the (mixing ratio of sample 7:10/1), sample 1 and sulphur
Sad (mixing ratio:10/1), sample 1 and sample 3 and sample 7 and lipoic acid (mixing ratio:10/1/1/1) in any one 200
Add 50 parts of 40 parts of beeswax and evening primrose oil (EFAMOL companies of Britain (Britain エ Off ァ モ ー Le society)), heating mixing in part and
After homogenizing, it is supplied in capsule filling machine, the gelatin covered by soft gum that every 1 intragranular capacity is 250mg is studied by conventional method
Capsule preparation.The capsule preparations can be utilized as the dietary supplement of orally available intake, pharmaceuticals or animal feed.
Study example 2 (hard shell capsules)
By sample 1 and the (mixing ratio of sample 3:10/1), sample 1 and sample 4 and the (mixing ratio of sample 6:10/3/1), sample 1
And sample 4 and the (mixing ratio of sample 7:10/1/1), sample 1 and sample 4 and sample 5 and the (mixing ratio of sample 7:10/2/1/1) in
Any one is supplied in capsule filling machine, and studying the gelatin that every 1 intragranular capacity is 200mg by conventional method coats hard shell capsules
Preparation.The capsule preparations can be utilized as the dietary supplement of orally available intake, pharmaceuticals or animal feed.
Study example 3 (beverage)
It is separately added into the commercially available nourishing beverages of 100mL:Sample 1 and the (mixing ratio of sample 3:10/1), sample 1 and sample
7 (mixing ratios:10/1), sample 1 and lipoic acid (mixing ratio:10/1) each 1000mL, is sufficiently mixed and studies beverage.Even if by its
Being preserved in refrigerator will not also find that outward appearance and local flavor are abnormal and unnatural for 6 months.This product can be as improving dry, bullet
Property reduction, pachylosis etc. skin condition and/or promote the beverage or potus of U.S. flesh and be utilized.
Industrial applicability
Containing by collagen peptide and selected from above-mentioned specific three kinds of improving blood flow agent one or more kinds of groups
Into of the invention U.S. flesh accelerator of the thing as active ingredient is used together, due to by the way that its orally ingestible or administration are had
Improve drying, elasticity reduction, pachylosis and/or the effect for promoting U.S. flesh of skin, therefore, it is possible to diet product, pharmaceuticals,
The field of non-pharmaceutical products, feed etc. is effectively utilized.
Claims (8)
1. a kind of U.S. flesh accelerator, it is characterised in that only contain collagen peptide and improving blood flow agent as active ingredient,
The improving blood flow agent is the one or two selected from the group being made up of camellia seed extract and lipoic acid class, institute
It is the one or two selected from lipoic acid, its cyclodextrin inclusion compound to state lipoic acid class, and the lipoic acid is racemic modification.
2. U.S. flesh accelerator according to claim 1, it is characterised in that the lipoic acid class include from the lipoic acid,
The outer surface of the one or two kinds of crystallizations, powder and/or the particle that are selected in the cyclodextrin inclusion compound is by lipid cladding
The material of formation.
3. U.S. flesh accelerator according to claim 1, it is characterised in that the collagen peptide is collagen or gelatin
Hydrolyzable thing and mean molecule quantity be 200~10000.
4. U.S. flesh accelerator according to claim 1, it is characterised in that the camellia seed extract be by water and/or
Lower alcohol carries out the water composition obtained by extraction process to the degreasing dregs of rice of camellia seed.
5. the U.S. flesh accelerator according to claim 1 or 4, it is characterised in that the camellia seed extract is to contain saponin(e
The extract of class, the saponins is containing by Tsubaki-saponin A1, Tsubaki-saponin A2, Tsubaki-saponin B1, Camelliasaponin B2, camellia
The one or more kinds of saponinses selected in the group of saponin(e C1 and Tsubaki-saponin C2 compositions.
6. a kind of composition for oral administration of the U.S. flesh accelerator containing described in Claims 1 to 5 any one.
7. composition for oral administration according to claim 6, it is characterised in that the composition for oral administration is diet product.
8. a kind of beauty method, for the drying to skin, elasticity reduction, pachylosis skin condition improved and/or
Promote U.S. flesh, it is characterised in that the U.S. flesh accelerator described in orally ingestible Claims 1 to 5 any one.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011114156 | 2011-04-28 | ||
JP2011-114156 | 2011-04-28 | ||
CN201280020408.4A CN103501800B (en) | 2011-04-28 | 2012-04-26 | Beautiful-skin-promoting agent and use thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280020408.4A Division CN103501800B (en) | 2011-04-28 | 2012-04-26 | Beautiful-skin-promoting agent and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107050438A true CN107050438A (en) | 2017-08-18 |
Family
ID=47072357
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280020408.4A Active CN103501800B (en) | 2011-04-28 | 2012-04-26 | Beautiful-skin-promoting agent and use thereof |
CN201611137754.7A Pending CN107050438A (en) | 2011-04-28 | 2012-04-26 | Beautiful-skin-promoagent agent and use thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280020408.4A Active CN103501800B (en) | 2011-04-28 | 2012-04-26 | Beautiful-skin-promoting agent and use thereof |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6205616B2 (en) |
KR (1) | KR101840508B1 (en) |
CN (2) | CN103501800B (en) |
TW (1) | TWI436774B (en) |
WO (1) | WO2012147842A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108719215A (en) * | 2018-03-28 | 2018-11-02 | 宜州市壮之都丝绸家纺有限公司 | A kind of high-yield cultivation method of silkworm |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6026257B2 (en) * | 2012-12-11 | 2016-11-16 | 花王株式会社 | Ceramide production promoter |
JP6022333B2 (en) * | 2012-12-11 | 2016-11-09 | 花王株式会社 | Ceramide production promoter |
PL2948003T3 (en) | 2013-01-23 | 2021-01-25 | Bottled Science Limited | Skin enhancing beverage composition |
US10722436B2 (en) | 2015-08-10 | 2020-07-28 | Mary Kay Inc. | Topical compositions |
KR101853927B1 (en) | 2016-08-12 | 2018-05-02 | 주식회사 제이 | A cosmetic composition comprising enzymatic hydrolysate of salmon scaled with the excellent effect of skin exfoliation efficacy, itching improvement and scalp dandruff improvemtny |
KR102094061B1 (en) | 2017-09-18 | 2020-03-26 | 진명종 | Method of anti-wrinkle and Anti-aging cosmetics compositions using colloidal gold |
KR101961152B1 (en) * | 2017-11-15 | 2019-03-25 | 주식회사 프롬바이오 | Food composition or cosmetics for whitening, moisturizing or anti-aging of skin with sheep placenta and plant complex |
WO2020004585A1 (en) | 2018-06-29 | 2020-01-02 | ハウスウェルネスフーズ株式会社 | Composition for improving vascular endothelical function or improving blood flow in peripheral blood vessels |
KR20210047425A (en) | 2019-10-21 | 2021-04-30 | 코스맥스 주식회사 | Cosmetic Composition for Enhancing Skin |
KR20230096601A (en) | 2021-12-23 | 2023-06-30 | 주식회사 앤나코스메틱 | Serum cosmetics composition effective for anti-wrinkle and hypopigmentation containing gold grain |
TWI824585B (en) * | 2022-06-27 | 2023-12-01 | 孟鄉生化科技股份有限公司 | Polymer film |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759747A (en) * | 2004-09-27 | 2006-04-19 | 三得利株式会社 | Composition containing proanthocyanidin and sphingolipid |
JP2006166807A (en) * | 2004-12-16 | 2006-06-29 | Takafumi Ishikawa | Health and beauty food |
JP2010265251A (en) * | 2009-05-13 | 2010-11-25 | Bhn Kk | Bloodstream-promoting/improving agent |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0661051B1 (en) * | 1993-10-11 | 2006-01-11 | VIATRIS GmbH & Co. KG | Medicament for the treatment of hypertension. |
JP4336486B2 (en) * | 2002-10-04 | 2009-09-30 | 一丸ファルコス株式会社 | Hyaluronic acid production promoter |
JP4076477B2 (en) * | 2003-05-28 | 2008-04-16 | 株式会社クラレ | Skin preparation |
JP5016535B2 (en) * | 2008-03-27 | 2012-09-05 | 株式会社 資生堂 | Anti-aging food supplements and anti-aging agents |
JP4420357B1 (en) * | 2009-03-24 | 2010-02-24 | 株式会社資生堂 | Hyaluronic acid production promoter |
JP4420358B1 (en) * | 2009-03-27 | 2010-02-24 | 株式会社資生堂 | Hyaluronic acid production promoter |
JP4413272B1 (en) * | 2009-04-06 | 2010-02-10 | 株式会社資生堂 | Hyaluronic acid production promoter |
JP2011195504A (en) * | 2010-03-19 | 2011-10-06 | Shiseido Co Ltd | Hyaluronic acid production promoter, anti-ageing agent and wrinkle-ameliorating agent |
JP2012067082A (en) * | 2010-08-23 | 2012-04-05 | Yuki Yamashita | Oral composition |
JP2012056919A (en) * | 2010-09-13 | 2012-03-22 | Shiseido Co Ltd | Hyaluronic acid production promotor |
JP2012121871A (en) * | 2010-12-10 | 2012-06-28 | Shiseido Co Ltd | Agent for improving skin barrier function |
-
2012
- 2012-04-26 JP JP2012115029A patent/JP6205616B2/en active Active
- 2012-04-26 CN CN201280020408.4A patent/CN103501800B/en active Active
- 2012-04-26 WO PCT/JP2012/061191 patent/WO2012147842A1/en active Application Filing
- 2012-04-26 KR KR1020137026500A patent/KR101840508B1/en active IP Right Grant
- 2012-04-26 CN CN201611137754.7A patent/CN107050438A/en active Pending
- 2012-04-27 TW TW101115224A patent/TWI436774B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759747A (en) * | 2004-09-27 | 2006-04-19 | 三得利株式会社 | Composition containing proanthocyanidin and sphingolipid |
JP2006166807A (en) * | 2004-12-16 | 2006-06-29 | Takafumi Ishikawa | Health and beauty food |
JP2010265251A (en) * | 2009-05-13 | 2010-11-25 | Bhn Kk | Bloodstream-promoting/improving agent |
Non-Patent Citations (2)
Title |
---|
夏涛: "《茶叶深加工技术》", 27 February 2011 * |
野崎勉: "最近の美容素材の開発トレンド", 《食品と開発》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108719215A (en) * | 2018-03-28 | 2018-11-02 | 宜州市壮之都丝绸家纺有限公司 | A kind of high-yield cultivation method of silkworm |
Also Published As
Publication number | Publication date |
---|---|
WO2012147842A1 (en) | 2012-11-01 |
TWI436774B (en) | 2014-05-11 |
TW201300136A (en) | 2013-01-01 |
KR20140027947A (en) | 2014-03-07 |
CN103501800A (en) | 2014-01-08 |
CN103501800B (en) | 2017-01-18 |
KR101840508B1 (en) | 2018-03-20 |
JP6205616B2 (en) | 2017-10-04 |
JP2012236826A (en) | 2012-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103501800B (en) | Beautiful-skin-promoting agent and use thereof | |
JP2008280271A (en) | Agent for preventing photoaging of skin | |
CN108402465A (en) | A kind of micro-capsule compound powder and its preparation process containing peculiar smell oils | |
JP2008137998A (en) | Skin ameliorating agent and oral composition for beauty and health | |
JP5685752B2 (en) | Blood flow promoting agent | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
Daniloski et al. | Recent developments on Opuntia spp., their bioactive composition, nutritional values, and health effects | |
JP2007049952A (en) | Noodle string dough and method for producing the same | |
JP5066725B2 (en) | Fat absorption inhibitor, fat accumulation inhibitor or fat burning accelerator | |
JP5066670B2 (en) | Anti-obesity agent and edible composition | |
JPWO2009048120A1 (en) | Astaxanthin-containing water-soluble composition | |
JP5597828B2 (en) | Hair restorer | |
JP2003055244A (en) | Agent promoting hyaluronic acid production, cosmetics, food and beverage including the hyaluronic acid production-promoting agent | |
JP2008239505A (en) | Neuroblast growth promoter and neurite extender | |
JP2008280310A (en) | Promoter for forming and metabolizing testosterone | |
JP2007131579A (en) | Physiologically active composition and method for producing the same | |
JP2002068993A (en) | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic | |
JP2017193497A (en) | Muscle-enhancing agent | |
CN110237117A (en) | A kind of soft capsule and preparation method thereof of Menopause anti-aging | |
JP2008163004A (en) | Fat accumulation inhibitor | |
JP2008163003A (en) | Fat absorption inhibitor | |
JP2012067082A (en) | Oral composition | |
JP2004331543A (en) | Fibroblast growth-promoting agent and skin cosmetic and beauty food or drink | |
RU2602608C1 (en) | Functional food products and method for production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1242623 Country of ref document: HK |
|
CB02 | Change of applicant information |
Address after: Tokyo, Japan, Japan Applicant after: Biaiqien Co., Ltd. Address before: Tokyo, Japan, Japan Applicant before: Bi En limited company |
|
CB02 | Change of applicant information | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170818 |
|
WD01 | Invention patent application deemed withdrawn after publication |